These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 33388041)

  • 1. Delphi consensus on strategies in the management of opioid-induced constipation in cancer patients.
    Sarrió RG; Calsina-Berna A; García AG; Esparza-Miñana JM; Ferrer EF; ; Porta-Sales J
    BMC Palliat Care; 2021 Jan; 20(1):1. PubMed ID: 33388041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid-Induced Constipation in Oncological Patients: New Strategies of Management.
    Mesía R; Virizuela Echaburu JA; Gómez J; Sauri T; Serrano G; Pujol E
    Curr Treat Options Oncol; 2019 Dec; 20(12):91. PubMed ID: 31853656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rates of appropriate laxative prophylaxis for opioid-induced constipation in veterans with lung cancer: a retrospective cohort study.
    Brown TJ; Keshvani N; Gupta A; Yang H; Agrawal D; Le TC; Gerber DE; Alvarez CA
    Support Care Cancer; 2020 Nov; 28(11):5315-5321. PubMed ID: 32124025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid-induced constipation, use of laxatives, and health-related quality of life.
    Christensen HN; Olsson U; From J; Breivik H
    Scand J Pain; 2016 Apr; 11():104-110. PubMed ID: 28850447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of Opioid-Induced Constipation and Bowel Dysfunction: Expert Opinion of an Italian Multidisciplinary Panel.
    De Giorgio R; Zucco FM; Chiarioni G; Mercadante S; Corazziari ES; Caraceni A; Odetti P; Giusti R; Marinangeli F; Pinto C
    Adv Ther; 2021 Jul; 38(7):3589-3621. PubMed ID: 34086265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into the Use of Peripherally Acting μ-Opioid Receptor Antagonists (PAMORAs) in Oncologic Patients: from Scientific Evidence to Real Clinical Practice.
    Fernández-Montes A; de Velasco G; Aguín S; Farriols C; Guirado-Risueño M; Jerviz-Guía VG; Baeza-Nadal MV; Chicas-Sett R; Fírvida JL; García-Navalón F; Martín P; Perezagua-Marín C; Rodríguez D; Santamaría J; Saurí T; Cobo M
    Curr Treat Options Oncol; 2021 Feb; 22(3):26. PubMed ID: 33635493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid induced constipation management in orthopaedic and trauma patients: treatment and the potential of nurse-initiated management.
    Sonneborn O; Bui T
    Int J Orthop Trauma Nurs; 2019 Aug; 34():16-20. PubMed ID: 31126838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of naloxegol on symptoms and quality of life related to opioid-induced constipation in patients with cancer: a 3-month follow-up analysis.
    Cobo Dols M; Beato Zambrano C; Cabezón Gutiérrez L; Chicas Sett R; Blancas López-Barajas MI; García Navalón F; Fírvida Pérez JL; Serrano Bermúdez G; Togores Torres P; Delgado Mingorance I; Giraldo Marín A; Librán Oriol A; Paredes Lario A; Sánchez Mauriño P; Higuera Gómez O; Moreno Muñoz D; Jiménez López AJ; Huerta González I; Sanz Yagüe A; Soler López B
    BMJ Support Palliat Care; 2021 Mar; 11(1):25-31. PubMed ID: 32376758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of opioid-induced constipation in pregnancy: a concise review with emphasis on the PAMORAs.
    Li Z; Pergolizzi JV; Huttner RP; Zampogna G; Breve F; Raffa RB
    J Clin Pharm Ther; 2015 Dec; 40(6):615-9. PubMed ID: 26573866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of the European Consensus on the treatment of opioid-induced constipation analgesic drugs.].
    Falbo PT; Cereda V; Manna G; Iannace A; Menghi A; Corona M; Lanzetta G
    Recenti Prog Med; 2019; 110(7):338-342. PubMed ID: 31379368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating naloxegol for the treatment of opioid-induced constipation.
    Daniali M; Nikfar S; Abdollahi M
    Expert Opin Pharmacother; 2020 Jun; 21(8):883-891. PubMed ID: 32129103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Survey of Prophylactic Administration of Naldemedine for Opioid-induced Constipation].
    Ozawa Y; Haruki Y; Ohata M; Isono H; Takahashi M; Tate A; Ukita S; Hayashi S
    Yakugaku Zasshi; 2023; 143(2):183-189. PubMed ID: 36724931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid-induced Constipation: A Review of Health-related Quality of Life, Patient Burden, Practical Clinical Considerations, and the Impact of Peripherally Acting μ-Opioid Receptor Antagonists.
    Argoff CE
    Clin J Pain; 2020 Sep; 36(9):716-722. PubMed ID: 32554978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constipation in Cancer Patients - an Update of Clinical Evidence.
    Dzierżanowski T; Mercadante S
    Curr Treat Options Oncol; 2022 Jul; 23(7):936-950. PubMed ID: 35441979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost Effectiveness of Naloxegol for Opioid-Induced Constipation in the UK.
    Lawson R; Ryan J; King F; Goh JW; Tichy E; Marsh K
    Pharmacoeconomics; 2017 Feb; 35(2):225-235. PubMed ID: 27663572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with prolonged-release oxycodone/naloxone improves pain relief and opioid-induced constipation compared with prolonged-release oxycodone in patients with chronic severe pain and laxative-refractory constipation.
    Poelaert J; Koopmans-Klein G; Dioh A; Louis F; Gorissen M; Logé D; Van Op den Bosch J; van Megen YJ
    Clin Ther; 2015 Apr; 37(4):784-92. PubMed ID: 25757607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Use of Peripheral μ-Opioid Receptor Antagonists (PAMORA) in the Management of Opioid-Induced Constipation: An Update on Their Efficacy and Safety.
    Pergolizzi JV; Christo PJ; LeQuang JA; Magnusson P
    Drug Des Devel Ther; 2020; 14():1009-1025. PubMed ID: 32210534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of Opioid-induced Constipation in Older Adults.
    Horrigan J; Bhumi S; Miller D; Jafri M; Tadros M
    J Clin Gastroenterol; 2023 Jan; 57(1):39-47. PubMed ID: 36504229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid-induced constipation: a stepwise treatment algorithm feasibility study.
    Davies AN; Leach C; Butler C; Patel SD; Shorthose K; Batsari K
    BMJ Support Palliat Care; 2023 Dec; 13(e2):e446-e453. PubMed ID: 34348942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnesium hydroxide versus macrogol/electrolytes in the prevention of opioid-induced constipation in incurable cancer patients: study protocol for an open-label, randomized controlled trial (the OMAMA study).
    Kistemaker KRJ; de Graeff A; Crul M; de Klerk G; van de Ven PM; van der Meulen MP; van Zuylen L; Steegers MAH
    BMC Palliat Care; 2023 Mar; 22(1):22. PubMed ID: 36915062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.